NL-OMON48091已完成不适用
Modelling fluctuations in blood glucose levels based on food intake and physical activity in patients with Diabetes Mellitus Type 2 - REMIND * pREdictive Modelling IN Diabetes
Ziekenhuisgroep Twente0 个研究点目标入组 5 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •* Is diagnosed with diabetes mellitus type 2
- •* Is aged between 25 and 70 years
- •* Receives diabetic treatment based on long term medication
- •* Has a BMI between 25 and 40 kg/m2
- •* Is able to do 30 min of walking at a steady pace
排除标准
- •* Is receiver of short term/acute diabetic medication.
- •* Has any gastrointestinal disorder that is expected to have clinical relevant effect on the uptake of nutrients from the gut.
- •* Has any medical condition that prevents performing the required procedures.
- •* Has uncontrolled thyroid diseases.
- •* Is allergic to any substance present in any of the standardized meals.
研究者
相似试验
尚未招募
不适用
pREdictive Modelling IN DiabetesDiabetes Mellitus Type 2NL-OMON27187Dr. G.D. Laverman, Internal medicine/nephrology, ZGT Hospital5
招募中
2 期
A real-world study of blood glucose fluctuation in newly diagnosed overweight type 2 diabetes mellitus by Qingre Lishi decoctiotype 2 diabetesITMCTR2024000006the First Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
招募中
不适用
A study of blood glucose fluctuation examined by continous glucose monitoring systemDiabetes MellitusJPRN-UMIN000002569Kobe University Graduate School of Medicine, Division of Diabetes, Metabolism and Endocrinology100
已完成
不适用
The relationship between blood glucose fluctuations and vascular endothelial dysfunction from CGM in type 2 diabetes mellitustype 2 diabetes mellitusJPRN-UMIN000007581First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan50
已完成
4 期
Study for the effect on blood glucose fluctuation by switching from DPP-4 inhibitor to SGLT2 inhibitor or to DPP-4 inhibitor/SGLT2 inhibitor combination tablet in patients with type 2 diabetes. - multicenter, prospective, randomized, open-label, parallel group, comparison studytype 2 diabetes mellitusJPRN-UMIN000029628Hokkaido University Hospital101